Related references
Note: Only part of the references are listed.An Amyloid-β Cleaner for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction
Ruiyuan Liu et al.
ADVANCED SCIENCE (2020)
Ru@CeO2 yolk shell nanozymes: Oxygen supply in situ enhanced dual chemotherapy combined with photothermal therapy for orthotopic/subcutaneous colorectal cancer
Xufeng Zhu et al.
BIOMATERIALS (2020)
A Dual Functional Nanoreactor for Synergistic Starvation and Photodynamic Therapy
Yang Zhu et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Intelligently thermoresponsive flower-like hollow nano-ruthenium system for sustained release of nerve growth factor to inhibit hyperphosphorylation of tau and neuronal damage for the treatment of Alzheimer's disease
Hui Zhou et al.
BIOMATERIALS (2020)
Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases
Tim Bartels et al.
SCIENCE (2020)
Core-shell nanostructured electrocatalysts for water splitting
Xing Yin et al.
NANOSCALE (2020)
Sustained release of bioactive hydrogen by Pd hydride nanoparticles overcomes Alzheimer's disease
Lei Zhang et al.
BIOMATERIALS (2019)
Therapeutic applications of selenium nanoparticles
Amit Khurana et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Hollow Prussian Blue Nanozymes Drive Neuroprotection against Ischemic Stroke via Attenuating Oxidative Stress, Counteracting Inflammation, and Suppressing Cell Apoptosis
Kai Zhang et al.
NANO LETTERS (2019)
LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease
Bradlee L. Heckmann et al.
CELL (2019)
Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease
Wenshu Cong et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Versatile Polydopamine Platforms: Synthesis and Promising Applications for Surface Modification and Advanced Nanomedicine
Wei Cheng et al.
ACS NANO (2019)
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Justin M. Long et al.
CELL (2019)
Recent Advances in Nanozyme Research
Hui Wang et al.
ADVANCED MATERIALS (2019)
Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease
Jing Sun et al.
BIOMATERIALS (2019)
Chiral Molecule-mediated Porous CuxO Nanoparticle Clusters with Antioxidation Activity for Ameliorating Parkinson's Disease
Changlong Hao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Nanocomposites Inhibit the Formation, Mitigate the Neurotoxicity, and Facilitate the Removal of β-Amyloid Aggregates in Alzheimer's Disease Mice
Yu Zhao et al.
NANO LETTERS (2019)
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
Jiangjiexing Wu et al.
CHEMICAL SOCIETY REVIEWS (2019)
Custom-Made Ceria Nanoparticles Show a Neuroprotective Effect by Modulating Phenotypic Polarization of the Microglia
Feng Zeng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
Metal-involved theranostics: An emerging strategy for fighting Alzheimer's disease
Xiaohui Wang et al.
COORDINATION CHEMISTRY REVIEWS (2018)
Ultrasound-Excited Protoporphyrin IX-Modified Multifunctional Nanoparticles as a Strong Inhibitor of Tau Phosphorylation and beta-Amyloid Aggregation
Mengmeng Xu et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Microglia in neurodegeneration
Suzanne Hickman et al.
NATURE NEUROSCIENCE (2018)
Transferrin/aptamer conjugated mesoporous ruthenium nanosystem for redox-controlled and targeted chemo-photodynamic therapy of glioma
Xufeng Zhu et al.
ACTA BIOMATERIALIA (2018)
Comprehensive Insights into the Multi-Antioxidative Mechanisms of Melanin Nanoparticles and Their Application To Protect Brain from Injury in Ischemic Stroke
Yanlan Liu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
Microglia emerge as central players in brain disease
Michael W. Salter et al.
NATURE MEDICINE (2017)
Psychosocial stress on neuroinflammation and cognitive dysfunctions in Alzheimer's disease: the emerging role for microglia?
Sami Piirainen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
A Near-Infrared Responsive Drug Sequential Release System for Better Eradicating Amyloid Aggregates
Mengmeng Ma et al.
SMALL (2017)
Nanoparticles as potential clinical therapeutic agents in Alzheimer's disease: focus on selenium nanoparticles
Mustafa Naziroglu et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2017)
Oxidative stress, protein modification and Alzheimer disease
A. Tramutola et al.
BRAIN RESEARCH BULLETIN (2017)
Dietary Iron Oxide Nanoparticles Delay Aging and Ameliorate Neurodegeneration in Drosophila
Yi Zhang et al.
ADVANCED MATERIALS (2016)
Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer's Disease
Hyek Jin Kwon et al.
ACS NANO (2016)
Biocompatibility selenium nanoparticles with an intrinsic oxidase-like activity
Leilei Guo et al.
JOURNAL OF NANOPARTICLE RESEARCH (2016)
Polyoxometalate-based nanozyme: Design of a multifunctional enzyme for multi-faceted treatment of Alzheimer's disease
Nan Gao et al.
NANO RESEARCH (2016)
Immune attack: the role of inflammation in Alzheimer disease
Frank L. Heppner et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Carboxyfullerene Neuroprotection Postinjury in Parkinsonian Nonhuman Primates
Laura L. Dugan et al.
ANNALS OF NEUROLOGY (2014)
Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?
Torbjorn Persson et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
Innate immune activation in neurodegenerative disease
Michael T. Heneka et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes
Hui Wei et al.
CHEMICAL SOCIETY REVIEWS (2013)
Development, maintenance and disruption of the blood-brain barrier
Birgit Obermeier et al.
NATURE MEDICINE (2013)
The role of astrocytes in amyloid β-protein toxicity and clearance
Dietmar Rudolf Thal
EXPERIMENTAL NEUROLOGY (2012)
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Paula Agostinho et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain. A review
DA Butterfield
FREE RADICAL RESEARCH (2002)
Share Paper
